Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data

NCT06769646 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06769646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06769646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
December 2, 2024
Completion date
January 6, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2d) and chronic kidney disease (ckd)